Corneal epithelial permeability and dry eye treatment.
Benitez-del-Castillo
Jose M
JM
Unidad de Superficie e Inflamacion Ocular, Hospital Clinico San Carlos, Universidad Complutense de Madrid, Madrid, Spain.
Aranguez
Concha
C
Garcia-Sanchez
Julian
J
D000328:Adult; D001548:Benzalkonium Compounds; D003287:Contrast Media / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D015352:Dry Eye Syndromes / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism*; D019573:Epithelium, Corneal / Q000378:metabolism*; D005260:Female; D019793:Fluorescein / Q000493:pharmacokinetics; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D010539:Permeability; D011142:Polyvinyl Alcohol / Q000627:therapeutic use; D011310:Preservatives, Pharmaceutical; D012859:Sjogren's Syndrome / Q000150:complications
D001548:Benzalkonium Compounds; D003287:Contrast Media; D004338:Drug Combinations; D009883:Ophthalmic Solutions; D011310:Preservatives, Pharmaceutical; D011142:Polyvinyl Alcohol; D006820:Hyaluronic Acid; D019793:Fluorescein